Next Investors logo grey
  1. Home
  2. Biotech Companies

Biotech Companies

NTI’s two clinical trial results are in - Treatment success for BOTH Autism AND for Rett Syndrome

Next Investors Apr 17, 2024

Today, our biotech Investment Neurotech International (ASX: NTI) announced that BOTH of its clinical trials for Autism Spectrum Disorder (ASD) and Rett Syndrome had met the trials’ primary endpoints.

EMD up 37% on no news yesterday… MDMA Therapy for First Responders

Next Investors Mar 08, 2024

Yesterday, our biotech investment Emyria (ASX:EMD) was up 37% on no news.

eSense-Lab strikes JV to develop and a sell new range of terpene products

Finfeed Archived Jun 15, 2020

eSense-Lab Limited (ASX: ESE) has entered a JV with ANC Enterprises to provide specific terpenes uniquely developed for a range of skin care, hair care and hand sanitiser products. ANC will formulate and manufacture the resulting products containing ESE’s proprietary terpene mixes.

Plenty of run left in Genetic Signatures

Finfeed Archived May 11, 2020

There has been continual strong news flow from the Genetic Signature Ltd (ASX: GSS), as it received CE-IVD registration for its SARS-CoV-2 Detection Kit, as well as notification from the Therapeutic Goods Administration (TGA) that its EasyScreenTM SARS-CoV-2 Detection Kit has been approved to be listed on the ARTG in Australia.

Could PAA’s lead cancer drug treatment treat COVID-19?

Finfeed Archived Apr 17, 2020

PharmAust Limited (ASX: PAA) has entered into a Materials Transfer Agreement with the Walter and Eliza Hall Institute of Medical Research (WEHI) to test the effects of monepantel (MPL) on COVID-19 infections.

Join Our
Mailing List